MedCity Update – November 2015
View this email in your browser


From Eliot Forster, MedCity’s Executive Chair

More evidence, if evidence were needed, of the priority life sciences enjoys at the highest political levels came in October, when MedCity was delighted to be present at a high-level rountable meeting hosted by the Mayor of London and Life Sciences Minister George Freeman MP. The meeting sought to highlight the key needs of the sector, given its strategic importance to the greater south east and the UK economy, and challenges for the sector around infrastructure, long-term funding and access to the NHS were highlighted.

The Minister notes the success of MedCity’s Golden Triangle based activities, while the Mayor noted the critical importance of having a dedicated, informed Minister for Life Sciences. We are going to be working closely with the Office for Life Sciences and the GLA to build on the meeting, and we keep you in the loop as we progress.

In other news, thanks to all who came to MedTechSouthEast and Health Tech 2020 – both vibrant events that illustrated the variety and creativity of the medical technology sector. And looking forward, I hope that we’ll see many of you at our medtech networking event and Genesis 2015 in December – details about both are below.

10 new innovations win MedTechSouthEast

10 medtech innovations with the potential to keep people independent for longer, including ‘laser shoes’ for Parkinson’s and an evolving walking aid kit, have won a place on the MedTechSouthEast accelerator programme, developed by MedCity and Design Council.

The 10 winners claimed their place on the programme after pitching to a judging panel led by the Science Museum’s Roger Highfield.

Read more

Angels in MedCity presentation event 

The next Angels in MedCity entrepreneur pitching event takes place on Thursday 26 November, giving investors the chance to hear from exciting life sciences businesses.
Congratulations to Toothpick, one of the presenting companies at June’s pitching event, which has now been acquired by Dublin-based WhatClinic.
Find out more and register 


Read more about Angels in MedCity

Health Tech 2020 – forming winning consortia for EU funding

MedCity partnered with Research Media at the end of October to host Health Tech 2020 – a networking and matchmaking event to form winning consortia to target the two billion euros earmarked for health tech from upcoming EU Horizon 2020 calls. 

See social media coverage of the event

London MedTech: Innovation and Investment Trends

MedCity, SEHTA and the GLA are bringing together the medtech community for a free event at City Hall on Thursday 3 December.

The event will include views from key players in the sector including Johnson & Johnson Innovation, GE Healthcare and Microsoft on future trends, areas of investment for corporate R&D, and ways to encourage collaboration.

Read more and register

Dementia Discovery Fund launched 

The Dementia Discovery Fund, a global investment fund to support the development of new dementia treatments, has launched, raising $100m from investors including the UK’s Department of Health, Alzheimer’s Research UK and pharmaceutical companies including Biogen, GSK, Johnson & Johnson, Lilly, Pfizer and Takeda.

SV Life Sciences has been appointed as fund manager, and its Managing Partner Kate Bingham, a MedCity advisory board member, is part of the DDF team.

Read more

OneStart 2016 – open now

Got an innovative idea that could tackle some of the world’s most pressing healthcare challenges. OneStart, the world’s largest life sciences and healthcare start-up accelerator programme, is now open for it’s fourth year. For your chance to win £100k, free lab space and ongoing industry mentoring, apply now.

Find out more and apply

Read more about 2015’s winning team

Genesis 2015

MedCity is a Gold Sponsor of Genesis 2015, which takes place on Thursday 10 December at the QEII Centre, London.

With an over-arching theme of Taking Bio-Innovation to the Global Market, the speakers and panellists will focus on key components for success. Confirmed speakers include senior executives from the global investment, pharma, healthcare and advisory sectors.

Read more and register

A gene editing first and a science ‘Oscar’

Golden Triangle science has been making headlines, with a gene editing world first at Great Ormond Street for a child with leukaemia and a Breakthrough Prize – also known as the science Oscars – for a UCL Alzheimer’s researcher. 

Read about Great Ormond Street’s life saving gene editing work

Read about the Breakthrough Prize for UCL’s John Hardy

Oxford named a Precision Medicine Catapult centre of excellence

Oxford has been named as one of the Precision Medicine Catapult’s regional centres of excellence, alongside Belfast, Cardiff, Glasgow, Leeds and Manchester. Each centre will act as a hub for precision medicine activities in the region, coordinated by the Cambridge HQ.
Read more


Eliot Forster welcomes the creation of the Precision Medicine Catapult national network

Patent Box – consultation launched

In October a consultation was launched by HMRC around proposed changes to the design of the UK Patent Box to comply with a new international framework for preferential tax regimes. 

Read more about the consultation

Join MedCity at Biotech Showcase 2016 in San Francisco

MedCity is a sponsor of Biotech Showcase 2016, taking place in San Francisco 11-13 January, and will host an hour-long workshop panel on the re-emergence of the London Stock Exchange as a listing venue for life sciences.

Biotech Showcase features company presentations to potential investors and partners, and companies that quote MedCity in their presenter request forms will receive a $200 discount on event registration.

Find out more and apply to present here

Imaging for dementia drug research – Imanova and Imperial collaborate

Imanova and Imperial College London are partnering as part of Dementias Platform UK’s new Imaging Network to apply PET-MRI scanners to dementia drug research.
Find out more

NICE launches initiative to speed up health tech

NICE announces the launch of the Office for Market Access to work with industry to speed up the adoption of new medicines, devices, and diagnostics by the NHS. 
Find out more

R&D tax credits for small businesses

David Gauke, Financial Secretary to the Treasury, announcing NICE announces a new plan outlining how the Government plans to make it easier for small businesses investing in R&D to claim tax credit. The two year plan responds to an HMRC consultation. 
Find out more

Funding call – UK-India partnerships

Innovate UK and the Government of India will invest up to £3.4m in collaborative R&D projects focused on affordable healthcare, ICT and clean-tech energy. The deadline for applications is 13 April 2016. 

Find out more and apply

Coming up


Japanese legislation for accelerating drug development – webinar, Export to Japan, 18 November
BioBeat15, BioBeats, 20 November
CEO & Investor Networking Forum, OBN, 24 November

Annual bioProcessUK Conference, BIA, 25 November
Innovation in the NHS, Innovation Forum Oxford, 30 November
Internet of Things in Healthcare and Medical Devices, Innovation Forum Oxford, 13 December
Biotech Showcase 2016, EBD Group, 11-13 January

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in December.


Copyright © 2015 MedCity. All rights reserved.